New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2013
19:22 EDTSNTSSantarus sees FY12 net income meeting or exceeding $12M-$14M
This includes the impact of the approximately $4M success-based regulatory milestone expense in 1Q12 related to Uceris and a $10M expense for the success-based clinical milestone for Ruconest in Q4.
News For SNTS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SNTS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use